Bending Spoons Files for U.S. IPO, Italian Acquirer Expands
The Milan-based Italian acquirer, known for reviving fading apps, has filed for a U.S. IPO, revealing sharp revenue g...
When To Prefer Bonds Over Sp500 In Retirement
Explore when bonds may be preferred over the Sp500 in retirement and how a cautious mix can protect assets while supporting withdrawals. This intro covers key timing considerations and conservative principles.
23,766 articles
Ranking Market’s Bets on OpenAI, Stripe & Consensys IPOs
OpenAI leads the 2026 IPO chatter, with Stripe and Consensys jockeying for position as investors weigh odds, valuatio...
Could Dogecoin (DOGE) Be Setting Up for a Big Move?
Dogecoin nudges higher near a major support zone as on-chain metrics show heavy demand. Could dogecoin (doge) setting...
Elon Musk Reveals Insane Plan to Double Chip Output
Elon Musk has floated a colossal Terafab project aimed at dramatically scaling U.S. chip production from a single pla...
A $200 Million Boomer Estate Sparks Wealth-Transfer Debate
A legendary film figure's passing has ignited a dispute over a $200 million boomer estate, putting liquidity and trus...
America’s Emergency Reserve About Hitting Reagan-Era Lows
The U.S. emergency oil stockpile is near its lowest level since 1983, with continued releases and global supply disru...
Shakeout Sparks Interest: $2,000? This Stock 27-Year Dividend
A trusted industrial name with a 27-year dividend growth streak trades lower amid volatility. We analyze why this sto...
Oracle’s Stock Slides After Earnings Beat, AI Costs Spark
Oracle beat on earnings and grew its contract backlog to a record level, yet investors pounced on higher AI costs, se...
Hungary Plans Decriminalize Cryptocurrency Trading Soon
Hungary’s new government unveiled a policy shift to decriminalize crypto trading, aiming for EU-aligned oversight and...
Charles Barkley Says Hopes About ESPN Firing and Finances
A high-profile moment on television can ripple through a star's bank account. This article dissects what the Barkley ...
Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Is Viking Therapeutics Stock Going to $100? Key Signals
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status